Somerset Group’s AbbVie ABBV Stock Holding History

Somerset Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.69M	Hold	6,803	–	–	1.18%	29
2026 Q1	$1.42M	Hold	6,803	–	–	1.05%	31
2025 Q4	$1.59M	Hold	6,803	–	–	1.2%	27
2025 Q3	$1.58M	Hold	6,803	–	–	1.25%	27
2025 Q2	$1.26M	Hold	6,803	–	–	1.07%	29
2025 Q1	$1.43M	Hold	6,803	–	–	1.3%	25
2024 Q4	$1.21M	Hold	6,803	–	–	1.1%	26
2024 Q3	$1.34M	Hold	6,803	–	–	1.24%	26
2024 Q2	$1.17M	Hold	6,803	–	–	1.04%	27
2024 Q1	$1.24M	Sell	6,803 -600	-8%	-$103K	1.16%	26
2023 Q4	$1.15M	Hold	7,403	–	–	0.96%	30
2023 Q3	$1.1M	Sell	7,403 -771	-9%	-$113K	1.04%	29
2023 Q2	$1.1M	Sell	8,174 -35	-0.4%	-$5.13K	0.92%	31
2023 Q1	$1.31M	Buy	8,209 +20	+0.2%	+$3.06K	1.14%	27
2022 Q4	$1.32M	Sell	8,189 -700	-8%	-$107K	1.17%	26
2022 Q3	$1.19M	Hold	8,889	–	–	1.09%	25
2022 Q2	$1.36M	Sell	8,889 -22	-0.2%	-$3.36K	1.18%	25
2022 Q1	$1.45M	Hold	8,911	–	–	1.04%	26
2021 Q4	$1.21M	Hold	8,911	–	–	0.81%	32
2021 Q3	$961K	Sell	8,911 -400	-4%	-$45.7K	0.69%	33
2021 Q2	$1.05M	Buy	9,311 +58	+0.6%	+$6.53K	0.75%	34
2021 Q1	$1M	Sell	9,253 -200	-2%	-$21.4K	0.76%	33
2020 Q4	$1.01M	Buy	9,453 +52	+0.6%	+$5K	0.81%	31
2020 Q3	$823K	Buy	+9,401	New	+$885K	0.75%	31

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Somerset Group's ABBV Position: Q2 2026 in Review

Somerset Group held its AbbVie (ABBV) position steady in Q2 2026 at 6,803 shares worth $1.69M. The position accounts for 1.18% of the portfolio, ranked #29.

Somerset Group first reported a position in ABBV in Q3 2020 and has held it in 24 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Somerset Group held 6,803 shares of AbbVie worth $1.69M as of Q2 2026.
Somerset Group left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 1.18% of Somerset Group's portfolio in Q2 2026, its #29 holding.
Somerset Group first reported a position in AbbVie in Q3 2020 and has held it in 24 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Somerset Group's 13F filing for Q2 2026, filed 12 Aug 2026.